Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,593,278
+$9,166,069 QoQ
Shares Held
355,570
+2154.7% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 224 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Derivatives in MLYS

reported options exposure · as of Jun 30, 2026
CallValue
$3,609,924
CallShares
133,800
PutValue
$4,818,628
PutShares
178,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. MLYS ranks #31 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLYS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,609,924 133,800
2026-06-30 $4,818,628 178,600
2026-06-30 $9,593,278 355,570
2026-03-31 $19,664,631 725,900
2026-03-31 $427,209 15,770
2026-03-31 $18,762,534 692,600
2025-12-31 $5,197,018 143,208
2025-12-31 $20,714,332 570,800
2025-12-31 $17,553,473 483,700
2025-09-30 $2,169,896 57,223
2025-09-30 $1,403,040 37,000
2025-06-30 $338,250 25,000
2025-06-30 $758,843 56,086
2025-03-31 $206,440 13,000
2025-03-31 $986,846 62,144
2025-03-31 $282,664 17,800
2024-12-31 $151,979 12,346